Budget Battles
-
Republicans Want Strings Attached to California Disaster Aid
-
Biden Goes Out With a Bang in the Jobs Market
-
Trump Privately Pushes Senators for ‘One Big, Beautiful Bill’
-
Trump Considers Declaring National Emergency for Tariff Rollout
-
Trump Unloads: Grievances, Greenland and the Gulf of Mexico
-
Republicans Divided Over How to Pass Trump’s Agenda
-
Trump Pushes Johnson to Victory as Speaker
-
It May Sound Awful, but We Really Do Need to Pay for Human Organs
By Marc JoffeWith dialysis being so expensive, onerous and ultimately fatal, kidney patients and taxpayers would be better off with more donations.
-
Feds' Big Bust: $1.3 Billion Health Insurance Fraud Takedown
By Rob GarverOn the same day that Republican members of the Senate released a pair of bills aimed at repealing and replacing the Affordable Care Act, the Department of Justice highlighted a problem with the...
-
Where Do You Store Your Medical Info? Apple Wants It to Be Your iPhone
By Christina Farr, CNBCImagine turning to your iPhone for all your health and medical information — every doctor's visit, lab test result, prescription and other health information, all available in a snapshot on your...
-
How American Health Care Became a Big, Broken Business
Who’s to blame for the sad state of the American health care system in 2017? The short answer, as Dr. Elisabeth Rosenthal details in her new book “An American Sickness: How Healthcare Became Big...
-
Why You Should Think Twice Before Drinking That Can of Soda
By Barbara MoranNew research suggests that excess sugar—especially the fructose in sugary drinks—might damage your brain.
-
One Major Obamacare Insurance Company Is Close to Break Even This Year
By Eric PianinDespite high premiums and diminished consumer choices that might deter consumers from enrolling in Obamacare, a new financial analysis concludes that the individual health insurance market has shaken...
-
New Cancer Drugs Show Promise – and Sky-High Prices
By DEENA BEASLEY, ReutersNewer cancer drugs that enlist the body's immune system are improving the odds of survival, but competition between them is not reining in prices that can now top $250,000 a year. The drugs' success...
-
The Billion Dollar Drug for Opioid Victims Has a Problem: It’s Addictive
Maryland Gov. Larry Hogan’s executive order earlier this month, declaring the state’s opioid addiction crisis a state of emergency, is yet another example of the state’s leadership in addressing a...
-
Pfizer Chief Says Government Efforts to Contain Drug Prices Will Backfire
By Eric PianinIan C. Read, Pfizer’s hard-edged, Scottish-born CEO and chairman, has been unapologetic about his company’s dubious pricing practices. Last week, he gave no ground on the larger question about...
-
Trump’s Big Cuts to Medical Research May Not Get Past Congress
By Eric PianinNIH, Donald Trump, Paul Ryan, Joe Biden, cancer research, National Institutes of Health
-
School Nurses Gain Access to Kids’ Online Health Records
By Michelle Andrews, Kaiser Health NewsAlthough the school nurse is a familiar figure, school-based health care is unfamiliar territory to many medical professionals, operating in a largely separate health care universe from other...
-
GM Messes Up Again
By Marilyn W. Thompson and Paul Lienert, ReutersGeneral Motors on Tuesday apologized to families of accident victims who have been notified to bring in cars for replacement of defective ignition switches. "We are deeply sorry to those families who...
-
Apple Slices into Mobile Health Business with ‘Healthkit’
By Christina Farr, ReutersApple Inc took the wraps off a mobile application that can collect and analyze users' health data, part of a suite of new features outlined for its computing and mobile software, at its annual...
-
End-of-Life Doc Payment Plan Returns to the Fray
By Michael Ollove, StatelineThe federal government may reimburse doctors for talking to Medicare patients and their families about “advance care planning,” including living wills and end-of-life treatment options — potentially...
-
The $1,000 Pill That Calls for a 'National Dialogue'
By Julie Appleby, Kaiser Health NewsThe outcry continues over a $1,000 pill used to treat Hepatitis C made by California-based Gilead Sciences. While the drug is a significant advance over older treatments for the viral liver disease,...